Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Fondazione ENEA Tech e Biomedical Leads €13.6 Million Series B Funding Round for Newronika

Feb 14, 2025•over 1 year ago

Contract Type

partnership

MilanBiotechnologyHealth CareArtificial IntelligenceTherapeuticsMachine Learning

Description

Newronika has successfully closed its €13.6 million Series B funding round, led by Fondazione ENEA Tech e Biomedical. The investment will empower Newronika to expand the clinical validation and commercialization of its proprietary adaptive DBS system for Parkinson’s disease patients.

Company Information

Company

Newronika

Location

Milan, Lombardy, Italy

About

Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normal daily activities and improve quality of life.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Newronika's next move

Learn about Strategic plan

Agreement Insights

Based on industry data

Strategic partnership established

Partnership agreements typically involve technology integration and joint go-to-market strategies

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months